97 related articles for article (PubMed ID: 26602396)
1. [The Safety of Super-Selective Intra-Arterial Infusion Chemotherapy for Induction with Docetaxel, Cisplatin, and 5-Fluorouracil for Oral Cancer].
Hiraiwa T; Koike M; Okada H; Senda N; Suzuki K
Gan To Kagaku Ryoho; 2015 Nov; 42(11):1385-9. PubMed ID: 26602396
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
Huang CE; Lu CH; Chen PT; Chan CH; Chen WC; Wang WH; Wu JY; Kuan FC; Lee KD; Chen CC
J Clin Pharm Ther; 2012 Jun; 37(3):342-7. PubMed ID: 21950487
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of combination chemotherapy with oral S-1 administration followed by docetaxel by superselective intra-arterial infusion for patients with oral squamous cell carcinomas].
Nagai H; Takamaru N; Ohe G; Uchida D; Tamatani T; Fujisawa K; Iwamoto S; Miyamoto Y
Gan To Kagaku Ryoho; 2011 May; 38(5):777-81. PubMed ID: 21566436
[TBL] [Abstract][Full Text] [Related]
4. [Clinical phase I trial of S-1 in the combination with DOC using super-selective intra-arterial infusion with oral cancer].
Ueyama Y; Okafuji M; Harada K; Mano T; Mihara M; Uchida K; Horinaga D; Wada N
Gan To Kagaku Ryoho; 2009 Mar; 36(3):395-9. PubMed ID: 19295262
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of nimotuzumab combined with docetaxel-cisplatin-fluorouracil regimen in treatment of advanced oral carcinoma.
Meng J; Gu QP; Meng QF; Zhang J; Li ZP; Si YM; Guo W; Zhuang QW
Cell Biochem Biophys; 2014 Jan; 68(1):181-4. PubMed ID: 23733674
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the efficacy and safety of continuous arterial infusion chemotherapy with cisplatin and 5-fluorouracil in treating oral cancer.
Ye M; Li X; Liu W; Tao H; Yan J
J Cancer Res Ther; 2016 Oct; 12(Supplement):47-49. PubMed ID: 27721252
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy with docetaxel, 5-FU and CDDP (DFP) for advanced gastric cancer.
Yamamoto K; Fujiwara Y; Nishida T; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Mori M; Doki Y
Anticancer Res; 2009 Oct; 29(10):4211-5. PubMed ID: 19846975
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.
Bae WK; Hwang JE; Shim HJ; Cho SH; Lee JK; Lim SC; Chung WK; Chung IJ
Cancer Chemother Pharmacol; 2010 Feb; 65(3):589-95. PubMed ID: 19830427
[TBL] [Abstract][Full Text] [Related]
9. Complete response of huge buccal malignant melanoma in an octogenarian patient to arterial chemotherapy.
Wu CF; Wu CS; Yu WW; Huang MY
Head Neck; 2015 Oct; 37(10):E134-8. PubMed ID: 25521097
[TBL] [Abstract][Full Text] [Related]
10. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
[TBL] [Abstract][Full Text] [Related]
11. [Superselective intra-arterial infusion therapy with docetaxel, cisplatin and 5-fluorouracil for head and neck cancer--for tongue cancer patients in comparison patients with other therapies].
Furusaka T
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1241-6. PubMed ID: 16969018
[TBL] [Abstract][Full Text] [Related]
12. Oral cryotherapy for prophylaxis of oral mucositis caused by docetaxel, cisplatin, and fluorouracil chemotherapy for esophageal cancer.
Okamoto K; Ninomiya I; Yamaguchi T; Terai S; Nakanuma S; Kinoshita J; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Esophagus; 2019 Apr; 16(2):207-213. PubMed ID: 30600487
[TBL] [Abstract][Full Text] [Related]
13. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.
Mitsudo K; Koizumi T; Iida M; Iwai T; Nakashima H; Oguri S; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
Radiother Oncol; 2014 May; 111(2):306-10. PubMed ID: 24746571
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy in technically unresectable locally advanced oral cavity cancers: does it make a difference?
Patil VM; Noronha V; Joshi A; Muddu VK; Gulia S; Bhosale B; Arya S; Juvekar S; Chatturvedi P; Chaukar DA; Pai P; D'cruz A; Prabhash K
Indian J Cancer; 2013; 50(1):1-8. PubMed ID: 23713035
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
[TBL] [Abstract][Full Text] [Related]
16. Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center.
Patil VM; Chakraborty S; Shenoy PK; Manuprasad A; Sajith Babu TP; Shivkumar T; Babu S; Bhatterjee A; Balasubramanian S
Indian J Cancer; 2014; 51(1):69-72. PubMed ID: 24947100
[TBL] [Abstract][Full Text] [Related]
17. Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer.
Kobayashi W; Teh BG; Sakaki H; Sato H; Kimura H; Kakehata S; Nagahata M
Oral Oncol; 2010 Dec; 46(12):860-3. PubMed ID: 21050802
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
Takácsi-Nagy Z; Hitre E; Remenár É; Oberna F; Polgár C; Major T; Gödény M; Fodor J; Kásler M
Strahlenther Onkol; 2015 Aug; 191(8):635-41. PubMed ID: 25782685
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma.
Tanaka Y; Yoshida K; Yamada A; Tanahashi T; Okumura N; Matsuhashi N; Yamaguchi K; Miyazaki T
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1143-52. PubMed ID: 26896963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
